Purchase Order 75N92021P00169
Award Date
5/21/21
Potential Completion Date
6/30/22
Potential Value
$50K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Alstem, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Pablo, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Human Genome Research Institute awarded a $20,000 firm fixed price purchase order to Alstem, Inc. of San Pablo, California. Under the terms of the contract, Alstem will provide induced pluripotent stem cell generation from human fibroblasts using an episomal method. The work will be conducted at Alstem's place of performance in San Pablo and will be completed by December 31, 2023. No major subcontractors or set aside designations were identified....
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business, for a firm-fixed-price purchase order in the amount of $63,000.00. The contract calls for the use of CRISPR gene editing technology to create two custom induced pluripotent stem cell (iPSC) reporter cell lines - one with dual gene knock-ins for albumin and alpha-fetoprotein, and...
This is a $13,760 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. for the generation of point mutation induced pluripotent stem (iPS) or embryonic stem (ES) cell lines using CRISPR/Cas9 gene editing technology. The work is to be performed in Bethesda, MD and has a completion date of March 31, 2022. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that provides...
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
This is a $122,400.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Applied Stemcell, Inc., a minority-owned, woman-owned small business. The contract is for molecular and pathophysiological studies of Parkinson's disease dementia and does not have a set-aside designation. Applied Stemcell, Inc. provides gene editing services and good manufacturing practice (GMP) induced...
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Applied Stemcell, Inc., a minority owned, woman owned small business. The $17,400.00 Firm Fixed Price contract is for the investigation of cellular dysfunction associated with hereditary mutation within the prion gene, insertion of the gene mutation (D178N) into a 'normal' cell background, with production of heterozygous insert...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Applied Stemcell, Inc. for $9,027.20. The contract, which has no set-aside designation, was awarded on April 27, 2011 for gene editing services to generate customized cell and animal models, including knockout mouse models, reporter cell lines, and stem cell models with disease-associated...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Applied Stemcell, Inc. The contract is for $12,450.00 and has a completion date of September 24, 2019. Applied Stemcell, Inc. is a minority-owned, woman-owned small business that provides gene editing services and GMP iPSC manufacturing to support cell-based research projects. Through past federal contract awards, the company has provided gene editing...
This $238,000.00 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the New York Stem Cell Foundation, Inc., a non-profit organization that conducts stem cell research. The contract is for the derivation of induced pluripotent stem cells, which aligns with the foundation's work in generating stem cell lines, differentiating them into various cell types, and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development, a civilian agency of the U.S. government, to Affymetrix, Inc. for the delivery of arrays of human pluripotent stem cell lines. The contract has a ceiling value of $12,000.00 and a completion date of September 12, 2011. The contract does not have a set-aside designation. As this is a purchase order, the prime contractor Affymetrix, Inc. is the only party involved in the...